Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CHRO

Chromocell Therapeutics (CHRO) Stock Price, News & Analysis

Chromocell Therapeutics logo

About Chromocell Therapeutics Stock (NYSE:CHRO)

Advanced Chart

Key Stats

Today's Range
$1.23
$1.48
50-Day Range
$1.34
$13.50
52-Week Range
$4.50
$38.00
Volume
194,032 shs
Average Volume
47,337 shs
Market Capitalization
$8.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CHRO Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Ligand subsidiaries, Chromocell Therapeutics to merge
Chromocell Therapeutics Corp (CHRO)
Channel Therapeutics Corporation (CHRO)
See More Headlines

CHRO Stock Analysis - Frequently Asked Questions

Shares of Chromocell Therapeutics reverse split before market open on Wednesday, July 2nd 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, July 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Chromocell Therapeutics (CHRO) raised $7 million in an initial public offering (IPO) on Friday, February 16th 2024. The company issued 1,100,000 shares at a price of $6.00 per share.

Company Calendar

Today
8/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CHRO
Previous Symbol
NYSE:CHRO
CIK
1919246
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.38 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-453.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.60
Quick Ratio
0.60

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.65) per share
Price / Book
-0.81

Miscellaneous

Outstanding Shares
6,485,000
Free Float
5,039,000
Market Cap
$8.69 million
Optionable
N/A
Beta
3.63

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:CHRO) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners